Clinical trials: Chronic Hepatitis b With Multidrug Resistance
Chronic Hepatitis b With Multidrug Resistance
Tenofovir Combination or Mono-therapy for MDR CHB
Treatment of multidrug resistant (MDR) chronic hepatitis B (CHB) is still a challenging issue. Hence, the investigators will perform a multicenter prospective cohort study for the evaluation of tenofovir disoproxil fumarate…
- Trial name
- NCT03597633
- Where
- South Korea
- Volunteers
- 236 people
- Sponsor
- Korea University
Chronic Hepatitis B
Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection
Entecavir(ETV) plus Tenofovir Disoproxil Fumarate(TDF) combination will show effective antiviral activity and prevent further development of antiviral resistance in hepatitis B e antigen(HBeAg)-positive or -negative Chronic…
- Trial name
- NCT01594905
- Testing
- Entecavir + Tenofovir (MDR group)
- Volunteers
- 90 people
- Sponsor
- Yonsei University